• Eton Pharmaceuticals director Jennifer McKie Adams exercised employee stock options for 50,000 common shares on June 17, 2026 at USD 3.78.
• Adams sold 50,000 common shares the same day at a weighted average price of USD 32.48.
• Her direct ownership in the shares reported fell to zero following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Eton Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-26-021000), on June 17, 2026, and is solely responsible for the information contained therein.